FMISO
 | |
| Systematic (IUPAC) name | |
|---|---|
|
1-(2-Nitro-imidazolyl)-3-[18F]fluoro-2-propanol | |
| Identifiers | |
| ChemSpider | 396524 |
| Synonyms | [18F]FMISO; 1H-1-(3-[18F]fluoro-2-hydroxypropyl)-2-nitroimidazole |
| Chemical data | |
| Formula | C6H818FN3O |
| Molar mass | 188.15 g/mol |
FMISO or fluoromisonidazole is used as a PET radiotracer for imaging hypoxia when labeled with fluorine-18.[1]
References
- ↑ Rajendran, JG; Mankoff, DA; O'Sullivan, F; Peterson, LM; Schwartz, DL; Conrad, EU; Spence, AM; Muzi, M; Farwell, DG; Krohn, KA (1 April 2004). "Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging.". Clinical cancer research : an official journal of the American Association for Cancer Research 10 (7): 2245–52. PMID 15073099.
External links
- 18F-Fluoromisonidazole, Molecular Imaging and Contrast Agent Database (MICAD)
This article is issued from Wikipedia - version of the Saturday, September 12, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.